{"id":550842,"date":"2021-07-01T16:30:02","date_gmt":"2021-07-01T16:30:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=550842"},"modified":"2021-07-01T16:30:02","modified_gmt":"2021-07-01T16:30:02","slug":"coronary-stents-pipeline-analysis-key-medtech-companies-are-set-to-develop-new-devices-and-explore-countless-opportunities","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/coronary-stents-pipeline-analysis-key-medtech-companies-are-set-to-develop-new-devices-and-explore-countless-opportunities_550842.html","title":{"rendered":"Coronary Stents Pipeline Analysis: Key MedTech Companies are set to develop new devices and explore countless opportunities"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1625134623.png\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Coronary Stents Pipeline Analysis: Key MedTech Companies are set to develop new devices and explore countless opportunities\" src=\"https:\/\/www.abnewswire.com\/uploads\/1625134623.png\" alt=\"Coronary Stents Pipeline Analysis: Key MedTech Companies are set to develop new devices and explore countless opportunities\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>Coronary Stents Pipeline <\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight\u2019s Coronary Stents pipeline report gives detailed insights into the Coronary Stents pipeline landscape, including 20+ companies and 20+ pipeline devices. This report also examines the emerging Coronary Stents devices in depth, as well as the competitive landscape, in order to better understand the market.\n<\/div>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/uploads\/aa58668f910fc98f9f044f8bdf82735d.jpg\" alt=\"\" \/><\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>DelveInsight&rsquo;s <\/span><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/coronary-stents-pipeline-insight-and-competitive-landscape?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Coronary Stents pipeline report<\/a><\/strong><span> gives detailed insights into the Coronary Stents pipeline landscape, including <\/span><span>20+ <\/span><span>companies and<\/span><span> 20+<\/span><span> pipeline devices. This report also examines the emerging Coronary Stents devices in depth, as well as the competitive landscape, in order to better understand the market.<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Some of the Key Highlights from the Coronary Stents Pipeline Report<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span><strong>Boston Scientific Corporation&rsquo;s<\/strong> product, <\/span><span><strong>SYNERGYTM<\/strong> Everolimus-Eluting Platinum Chromium Coronary Stent System<\/span><span>, a coronary stent system designed to treat patients with a constricted blood vessel (coronary artery) due to coronary artery disease, was approved by the Food and Drug Administration (FDA) on August 11, 2020.&nbsp;<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span><strong>MedAlliance<\/strong> was awarded the fourth FDA Breakthrough Device Designation for its <\/span><strong>Sirolimus Drug-Eluting Balloon<\/strong><span> in the treatment of De Novo Coronary Lesions on March 3, 2021.<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>Xience Sierra Stent and Xience Alpine Everolimus Eluting Coronary Stent System<\/strong><span> by <\/span><span><strong>Abbott<\/strong> <\/span><span>are the approved devices available in the Coronary Stents Market.<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>Firesorb (MicroPort CRM), Virtue Sirolimus AngioInfusion Balloon (Orchestra BioMed), <\/strong><span>and others are among the pipeline devices which may soon join the Coronary Stents market.<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>Abbott, Terumo Corporation, Cook Medical, B. Braun Medical, Orchestra Biomed, Bioheart, MicroPort, ATEM <\/strong><span>and others are among the key MedTech companies which are active in the Coronary Stents market.<\/span><span>&nbsp;<\/span><\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>To know more, request sample @ <\/span><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/coronary-stents-pipeline-insight-and-competitive-landscape?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Coronary Stents Market&nbsp;<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Coronary Stent: Overview<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>Coronary stents are expandable tubular metallic devices that can be used to clear congested arteries in patients with underlying atherosclerosis. After the stent is inserted, the revascularization process is also known as percutaneous coronary intervention or coronary angioplasty.<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Different types of Coronary Stents<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Bare-Metal Stents<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>Bare metal stents are made of tiny mesh wired tubes that allow the clogged artery to be widened but do not include a polymer or drugs coating to help prevent re-blockage of the arteries. Patients who are allergic to specific polymers or who do not require drugs eluted from drug eluting stents can benefit from these stents.<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Drug-Eluting Stents<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>When the arteries are about to re-block, a drug-eluting stent is a bare-metal stent with a polymer covering that allows for the progressive release of drugs over a period of time. Drug-eluting stents help to reduce the odds of a repeat arterial blockage. These further are of two types: Permanent Polymer Drug-Eluting Stent and Bioresorbable Polymer Drug-Eluting Stent.<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>Have queries? Where are stents placed? Find out your answer @ <\/span><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/coronary-stents-pipeline-insight-and-competitive-landscape?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Coronary Stents Placement<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Coronary Stents Key Companies<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Abbott<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Terumo Corporation<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Cook Medical<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>B. Braun Medical<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Orchestra Biomed<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Bioheart<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>MicroPort<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>ATEM<\/span><\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Coronary Stents Assessment<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>By Product Type<\/strong><\/p>\n<\/li>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Drug Eluting Stents<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Bare Metal Stents<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Bioabsorbable Scaffolds<\/span><\/p>\n<\/li>\n<\/ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>By Stage Type<\/strong><span>&nbsp;<\/span><\/p>\n<\/li>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Pre-clinical<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Clinical<\/span><\/p>\n<\/li>\n<\/ul>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Coronary Stents Market Drivers<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Rising prevalence of cardiovascular diseases such as stroke and heart attack<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Increasing technological advancement&nbsp;<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Increasing levels of geriatric population that are at a risk of cardiac health<\/span><\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Coronary Stents Market Barriers<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Product Recalls<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Product-related safety concerns<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Stringent government approvals<\/span><\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span><strong>Coronary Stents Unmet Needs<\/strong>&nbsp;<\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Need for more emphasis on product safety<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Less health expenditure in low- and middle-income countries<\/span><\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Scope of the Report<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Coverage: <\/strong><span>Global<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Coronary Stents Key Companies: <\/strong><span>Abbott, Terumo Corporation, Cook Medical, B. Braun Medical, Orchestra Biomed, Bioheart, MicroPort, ATEM, among others<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>PEST Analysis<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Table of Contents<\/strong><\/p>\n<div style=\"text-align: justify;\" dir=\"ltr\" align=\"left\">\n<table>\n<colgroup>\n<col width=\"71\" \/>\n<col width=\"553\" \/><\/colgroup>\n<tbody>\n<tr>\n<td>\n<p dir=\"ltr\"><span>1.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Introduction<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>2.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Executive Summary<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>3.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Coronary Stents:&nbsp; Background and Overview<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>4.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Listing of Marketed Coronary Stents: Company Profiles<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>5.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Listing of Pipeline Coronary Stents: Company Profiles<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>6.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Coronary Stents: Competitive Assessment of Listed Products<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>7.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Coronary Stents: Competitive Benchmarking: By Company<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>8.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Coronary Stents &ndash; Commercialisation Activity<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>9.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Coronary Stents: Regulatory Overview<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>10.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Coronary Stents: Reimbursement Overview<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>11.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Coronary Stents: Market Dynamics<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>12.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>PEST Analysis&nbsp;<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>13.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Conclusion &amp; Future Growth Perspectives<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>14.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Appendix<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>15.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Report Methodology<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>16.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>DelveInsight Capabilities<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>17.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Disclaimer<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>18.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>About DelveInsight<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>For rich insights into Healthcare and Pharmaceutical News, visit <\/span><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Pharma, Healthcare and Biotech Blog Posts<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Related Reports<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/biopsy-devices-pipeline-insight-and-competitive-landscape?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Biopsy Devices Pipeline Insights<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>Get comprehensive analysis of <\/span><span>Biopsy Devices<\/span><span> pipeline devices and key companies including <\/span><strong>3DBiopsy Inc, CleveX, Inc., LX Medical Corp, Promaxo Inc, Zamar Care, Vascular BioSciences, Boston Scientific Corp,<\/strong><span> among others.<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>About DelveInsight<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance.&nbsp;<\/span>&nbsp;<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com\/_57048.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Shruti Thakur<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=coronary-stents-pipeline-analysis-key-medtech-companies-are-set-to-develop-new-devices-and-explore-countless-opportunities\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 9193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> NV<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"http:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"http:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=coronary-stents-pipeline-analysis-key-medtech-companies-are-set-to-develop-new-devices-and-explore-countless-opportunities\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Coronary Stents Pipeline DelveInsight\u2019s Coronary Stents pipeline report gives detailed insights into the Coronary Stents pipeline landscape, including 20+ companies and 20+ pipeline devices. This report also examines the emerging Coronary Stents devices in depth, as well as the competitive &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/coronary-stents-pipeline-analysis-key-medtech-companies-are-set-to-develop-new-devices-and-explore-countless-opportunities_550842.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,406,420,411,416],"tags":[],"class_list":["post-550842","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Science","category-Technology","category-World"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/550842","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=550842"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/550842\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=550842"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=550842"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=550842"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}